Evaluation of the Antimicrobial Potential and Toxicity of a Newly Synthesised 4-(4-(Benzylamino)butoxy)-9<i>H</i>-carbazole

One of the greatest threats to human and animal health is posed by infections caused by drug-resistant bacterial strains. Therefore, newly synthesised substances are tested for their antimicrobial activity. Carbazole derivatives seem to be promising antibacterial agents. This study aimed at investigating the toxicity and activity of newly synthesised, functionalised carbazole derivative 2 (4-(4-(benzylamino)butoxy)-9H-carbazole) against various microorganisms. Its antimicrobial potential against Gram-positive and Gram-negative bacteria, yeast, and filamentous fungi was examined according to CLSI (Clinical and Laboratory Standards Institute) standards. The tested compound was found to efficiently inhibit the growth of Gram-positive strains. The addition of carbazole derivative 2 at the concentration of 30 µg/mL caused inhibition of bacterial growth by over 95%. Moreover, about 50 and 45% limitation of Pseudomonas aeruginosa and Aspergillus flavus growth was observed in the samples incubated with the addition of 20 and 60 µg/mL of the compound, respectively. Its addition to the microbial cultures caused an increase in the permeability of the cellular membrane. Slight haemolysis of red blood cells was observed after 24-h treatment with carbazole derivative 2. On the other hand, human fibroblasts were found to be more sensitive to its effects. The activity of the tested compound indicates a possibility of its further modification in order to obtain effective drugs, especially against drug-resistant staphylococci

Antimicrobial Activity and Toxicity of Newly Synthesized 4-[4-(benzylamino)butoxy]-9<i>H</i>-carbazole Derivatives

One of the main challenges of medicinal chemistry is the search for new substances with antimicrobial potential that could be used in the fight against pathogenic microorganisms. Therefore, the antimicrobial activity of newly synthesized compounds is still being investigated. Carbazole-containing compounds appear to be promising antibacterial, antifungal, and antiviral agents. The aim of this study was to examine the antimicrobial potential and toxicity of newly synthesized isomeric fluorinated 4-[4-(benzylamino)butoxy]-9H-carbazole derivatives. Their antimicrobial activity against bacteria and fungi was tested according to CLSI guidelines. Similarly to previously studied carbazole-containing compounds, the tested derivatives showed the ability to effectively inhibit the growth of Gram-positive bacteria. The addition of carbazole derivatives 2, 4, and 8 at the concentration of 16 µg/mL caused the inhibition of S. aureus growth by over 60%. The MIC value of compounds 2–5 and 7–10 was 32 µg/mL for Staphylococcus strains. Gram-negative strains of E. coli and P. aeruginosa were found to be more resistant to the tested carbazole derivatives. E. coli cells treated with compounds 3 and 8 at a concentration of 64 µg/mL resulted in a greater-than-40% reduction in bacterial growth. In the case of the P. aeruginosa strain, all compounds in the highest concentration that we tested limited growth by 35–42%. Moreover, an over-60% inhibition of fungal growth was observed in the cultures of C. albicans and A. flavus incubated with 64 µg/mL of compounds 2 or 7 and 1 or 4, respectively. The hemolysis of red blood cells after their incubation with the tested carbazole derivatives was in the range of 2–13%. In the case of human fibroblast cells, the toxicity of the tested compounds was higher. Derivative 1, functionalized with fluorine in position 2 and its hydrobromide, was the least toxic. The obtained results indicated the antimicrobial potential of the tested 4-[4-(benzylamino)butoxy]-9H-carbazole derivatives, especially against S. aureus strains; therefore, it is worth further modifying these structures, in order to enhance their activity against pathogenic microorganisms

Novel cofactor-type inhibitors of NAD-dependent enzymes. NAD-based therapeutics.

In the past years, numerous studies of NAD-dependent biological processes have revealed various remarkable roles of NAD in cell biology and medicine. Enzymes utilize NAD for modification of DNA and proteins, formation of signal transduction agents, and as co-enzymes in redox reactions. Molecules affecting interactions of NAD with NAD-dependent or NAD-utilizing enzymes are now of great therapeutic interest ranging from aging to cancer. Herein we present our recent contribution to the new field of NAD-therapeutics

DESIGN AND SYNTHESIS OF NOVEL INHIBITORS OF INOSINE MONOPHOSPHATE DEHYDROGENASE

Inosine Monophosphate Dehydrogenase (IMPDH) is a well known therapeutic target for new drug development against organ transplant rejection, viral infection and cancer due to its key role in de novo synthesis of purine nucleotides. Following our discovery of mycophenolic adenine dinucleotide (MAD) analogues such as C2-MAD, we designed and synthesized a series of C2-MAD analogues and evaluated their activities against IMPDH (type I and type II). We introduced different functional groups at the 2-position of adenine improving the potency and selectivity of new compounds against the type I and type II isoforms of the human enzyme. We also designed and synthesized compounds with new linkages between adenosine and mycophenolic moiety. Some of them showed more potent inhibition of IMPDH than the parent MAD analogues

Selective inhibition of nicotinamide adenine dinucleotide kinases by dinucleoside disulfide mimics of nicotinamide adenine dinucleotide analogues

Diadenosine disulfide (5) was reported to inhibit NAD kinase from Lysteria monocytogenes and the crystal structure of the enzyme-inhibitor complex has been solved. We have synthesized tiazofurin adenosine disulfide (4) and the disulfide 5, and found that these compounds were moderate inhibitors of human NAD kinase (IC50 = 110 mu M and IC50 = 87 mu M, respectively) and Mycobacterium tuberculosis NAD kinase (IC50 = 80 mu M and IC50 = 45 mu M, respectively). We also found that NAD mimics with a short disulfide (-S-S-) moiety were able to bind in the folded (compact) conformation but not in the common extended conformation, which requires the presence of a longer pyrophosphate (-O-P-O-P-O-) linkage. Since majority of NAD-dependent enzymes bind NAD in the extended conformation, selective inhibition of NAD kinases by disulfide analogues has been observed. Introduction of bromine at the C8 of the adenine ring restricted the adenosine moiety of diadenosine disulfides to the syn conformation making it even more compact. The 8-bromoadenosine adenosine disulfide (14) and its di(8-bromoadenosine) analogue (15) were found to be the most potent inhibitors of human (IC50 = 6 mu M) and mycobacterium NAD kinase (IC50 = 14-19 mu M reported so far. None of the disulfide analogues showed inhibition of lactate-, and inosine monophosphate-dehydrogenase (IMPDH), enzymes that bind NAD in the extended conformation

Study on a New Steering Mechanism for Point-the-Bit Rotary Steerable System

This paper presents a novel steering mechanism embedded in a point-the-bit rotary steerable system (RSS) for oilfield exploitation. The new steering mechanism adopts a set of universal joints to alleviate the high alternative strain on drilling mandrel and employs a specially designed planetary gear small tooth number difference (PGSTD) to achieve directional steering. Its principle and characteristics are explained and examined through a series of analyses. First, the eccentric displacement vector of the offset point on the drilling mandrel is formulated and kinematic solutions are established. Next, structural design for the new steering mechanism is addressed. Then, procedures and program architectures for simulating offset state of the drilling mandrel and motion trajectory of the whole steering mechanism are presented. After that, steering motion simulations of the new steering mechanism for both 2D and 3D well trajectories are then performed by combining LabVIEW and SolidWorks. Finally, experiments on the steering motion control of the new steering mechanism prototype are carried out. The simulations and experiments reveal that the steering performance of the new steering mechanism is satisfied. The research can provide good guidance for further research and engineering application of the point-the-bit RSS